Companies House true 2025-01-01 2025-12-31 false 09369673 uk-bus:Director1 2025-01-01 2025-12-31 09369673 uk-bus:Director2 2025-01-01 2025-12-31 09369673 2025-01-01 2025-12-31 09369673 2025-12-31 09369673 uk-bus:EntityHasNeverTraded 2025-01-01 2025-12-31 09369673 uk-bus:FRS102 2025-01-01 2025-12-31 09369673 uk-bus:FullAccounts 2025-01-01 2025-12-31 09369673 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 09369673 2024-12-31 09369673 uk-bus:OrdinaryShareClass1 2025-01-01 2025-12-31 09369673 uk-bus:OrdinaryShareClass2 2025-01-01 2025-12-31 09369673 uk-bus:OrdinaryShareClass3 2025-01-01 2025-12-31 09369673 uk-bus:PreferenceShareClass1 2025-01-01 2025-12-31 09369673 uk-bus:PreferenceShareClass2 2025-01-01 2025-12-31 09369673 uk-bus:PreferenceShareClass3 2025-01-01 2025-12-31 09369673 uk-core:ShareCapitalPreferenceShares 2025-12-31 09369673 uk-core:ShareCapitalPreferenceShares 2024-12-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 09369673

NEURO HEALTH SCIENCE LIMITED

Dormant Accounts

31 December 2025

NEURO HEALTH SCIENCE LIMITED Registered Number 09369673

Balance Sheet as at 31 December 2025

2025 2024
£ £
Called up share capital not paid
100000
100000
Net assets
100000
100000
Issued share capital
100000 Ordinary Shares of £ 1 each 100000 100000
Total Shareholder funds
100000
100000

STATEMENTS

  1. For the year ending 31 December 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 31 December 2025

And signed on their behalf by:
Zhen CAI, Director